Comparison of bioavailability of krill oil versus fish oil and health effect
- PMID: 26357480
- PMCID: PMC4559234
- DOI: 10.2147/VHRM.S85165
Comparison of bioavailability of krill oil versus fish oil and health effect
Abstract
Background: The aim of this review is to summarize the effects of krill oil (KO) or fish oil (FO) on eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) incorporation in plasma phospholipids or membrane of red blood cells (RBCs) as shown in human and animal studies. Furthermore, we discuss the findings in relation to the possible different health effects, focusing on lipids, inflammatory markers, cardiovascular disease risk, and biological functions of these two sources of long-chain n-3 polyunsaturated fatty acids (PUFAs).
Methods: A literature search was conducted in PubMed in January 2015. In total, 113 articles were identified, but based on selection criteria, 14 original papers were included in the review.
Results: Studies on bioavailability of EPA and DHA from KO and FO in humans and animals are limited and the interpretation is difficult, as different amounts of EPA and DHA have been used, duration of intervention differs, and different study groups have been included. Two human studies--one postprandial study and one intervention study--used the same amount of EPA and DHA from KO or FO, and they both showed that the bioavailability of EPA and DHA from KO seems to be higher than that from FO. Limited effects of KO and FO on lipids and inflammatory markers in human and animal studies were reported. Gene expression data from animal studies showed that FO upregulated the cholesterol synthesis pathway, which was the opposite of the effect mediated by KO. KO also regulated far more metabolic pathways than FO, which may indicate different biological effects of KO and FO.
Conclusion: There seems to be a difference in bioavailability of EPA and DHA after intake of KO and FO, but more studies are needed before a firm conclusion can be made. It is also necessary to document the beneficial health effects of KO with more human studies and to elucidate if these effects differ from those after regular fish and FO intake.
Keywords: animal studies; cardiovascular disease; gene expression; human studies; inflammation; lipid metabolism; long-chain polyunsaturated fatty acids.
Similar articles
-
Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.Lipids Health Dis. 2015 Sep 2;14:99. doi: 10.1186/s12944-015-0109-z. Lipids Health Dis. 2015. PMID: 26328782 Free PMC article. Clinical Trial.
-
Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trial.Lipids Health Dis. 2015 Mar 15;14:19. doi: 10.1186/s12944-015-0015-4. Lipids Health Dis. 2015. PMID: 25884846 Free PMC article. Clinical Trial.
-
Lipase Treatment of Dietary Krill Oil, but Not Fish Oil, Enables Enrichment of Brain Eicosapentaenoic Acid and Docosahexaenoic Acid.Mol Nutr Food Res. 2020 Jun;64(12):e2000059. doi: 10.1002/mnfr.202000059. Epub 2020 May 4. Mol Nutr Food Res. 2020. PMID: 32304625
-
Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.Drug News Perspect. 2008 Dec;21(10):552-61. doi: 10.1358/dnp.2008.21.10.1314058. Drug News Perspect. 2008. PMID: 19221636 Review.
-
Krill products: an overview of animal studies.Nutrients. 2015 May 7;7(5):3300-21. doi: 10.3390/nu7053300. Nutrients. 2015. PMID: 25961320 Free PMC article. Review.
Cited by
-
Lipase-Catalyzed Preparation and Optimization of Structured Phosphatidylcholine Containing Nervonic Acid.Molecules. 2024 Mar 29;29(7):1539. doi: 10.3390/molecules29071539. Molecules. 2024. PMID: 38611818 Free PMC article.
-
Advances in Research on Marine-Derived Lipid-Lowering Active Substances and Their Molecular Mechanisms.Nutrients. 2023 Dec 15;15(24):5118. doi: 10.3390/nu15245118. Nutrients. 2023. PMID: 38140377 Free PMC article. Review.
-
Anti-Osteoarthritic Effects of Antarctic Krill Oil in Primary Chondrocytes and a Surgical Rat Model of Knee Osteoarthritis.Mar Drugs. 2023 Sep 28;21(10):513. doi: 10.3390/md21100513. Mar Drugs. 2023. PMID: 37888448 Free PMC article.
-
Krill oil treatment ameliorates lipid metabolism imbalance in chronic unpredicted mild stress-induced depression-like behavior in mice.Front Cell Dev Biol. 2023 Jul 26;11:1180483. doi: 10.3389/fcell.2023.1180483. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37564375 Free PMC article.
-
Dietary Protection against Cognitive Impairment, Neuroinflammation and Oxidative Stress in Alzheimer's Disease Animal Models of Lipopolysaccharide-Induced Inflammation.Int J Mol Sci. 2023 Mar 21;24(6):5921. doi: 10.3390/ijms24065921. Int J Mol Sci. 2023. PMID: 36982996 Free PMC article. Review.
References
-
- He K, Song Y, Daviglus ML, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation. 2004;109(22):2705–2711. - PubMed
-
- Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002;287(14):1815–1821. - PubMed
-
- Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) Lancet. 1989;2(8666):757–761. - PubMed
-
- Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet. 1999;354(9177):447–455. - PubMed
-
- Gissi-HF Investigators; Tavazzi L, Maggioni AP, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1223–1230. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials